Loading...
NPI 1558340034 · Los Angeles, CA · Cardiovascular Disease Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Mehran Khorsandi is a cardiovascular disease physician provider located in Los Angeles, California. This profile covers 85 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Mehran Khorsandi |
| Address | 8635 W 3rd St |
| City | Los Angeles |
| State | CA |
| ZIP | 90048 |
| Taxonomy | Cardiovascular Disease Physician |
| NPI Enumerated | January 12, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $6.1M |
| Medicaid | $1.4K |
Practice profile and service mix: The provider’s Medicare code mix is concentrated in vascular and cardiovascular interventional services — highest-revenue codes include 37229 ($1.2M), 36482 ($542.1K) and 37225 ($448.9K) and multiple angiography, stent, and intravascular ultrasound codes (36247, 37252, 37253) appear on the top-25 list. High volumes of PET myocardial imaging codes (78431, 78492, 78434), rubidium dosing (A9555), duplex vascular studies (93880, 93925, 93970) and monitoring/EKG codes (93229, 93000) indicate an integrated practice combining peripheral vascular intervention with vascular and cardiac imaging services, likely operating in ambulatory or outpatient interventional settings.
Revenue concentration on Medicare: The provider generates $6.1M in Medicare revenue with the precomputed top 3 Medicare codes accounting for 38.6% of that Medicare revenue; specifically, 37229 (20.8% of Medicare revenue), 36482 (9.7%) and 37225 (8.1%) are the primary revenue drivers. This concentration shows reliance on a small set of high-value vascular intervention procedures to drive a large share of Medicare income.
Payer mix and scale: This provider is effectively Medicare-centric — reported lifetime Medicare revenue is $6.1M versus just $1.4K in Medicaid revenue, indicating Medicaid is immaterial to the practice’s revenue mix and the provider operates at near single-payer scale with respect to public programs. The Medicaid top-3 share is precomputed at 100.0%, reflecting that the tiny Medicaid revenue is fully concentrated in a couple of low-dollar E/M and EKG services (99214 and 93000).
Competitive standing nationally on key interventional codes: Several high-revenue interventional and imaging codes are flagged as unusually concentrated for this provider — 36482 ranks #11 of 710 providers and is labeled an “extreme outlier, far above typical national volume,” and 36247 ranks #3 of 903 providers with the same “extreme outlier” designation. Additional procedure-level indicators such as 37252 (rank #24 of 1088, “extreme outlier”) and 37253 (rank #12 of 788, “extreme outlier”) support characterization of the provider as a major national outlier in peripheral vascular/interventional procedure volumes.
High ambulatory visit and care-management volume: The provider reports very high counts for office visits and care-management codes on Medicare — 99214 appears with 3.1K claims and $330.6K revenue and is labeled an “extreme outlier, far above typical national volume,” while 99490 has 2.5K claims ($137.2K) and a 99th percentile ranking. These counts suggest substantial ongoing outpatient management and longitudinal care activity in addition to procedure-based services, supporting a high-throughput clinic model.
Diagnostic and imaging footprint: The presence of high volumes and extreme-percentile rankings for noninvasive vascular diagnostics (93880 ranks in the 100th percentile; 93925 and 93970 rank in the 99th percentile) together with substantial PET myocardial imaging activity (78431, 78492) and rubidium dosing (A9555) points to a robust in-house imaging capability. That mix implies the practice performs end-to-end diagnostics and interventions — from duplex/echo/ECG through nuclear perfusion and interventional therapy — which can concentrate downstream procedural revenue.
Local (Medicaid) competitive position: Medicaid billing is negligible at $1.4K total, and the two Medicaid codes on file (99214 and 93000) rank in low in-state percentiles (99214 at the 18th percentile and 93000 at the 28th percentile), indicating a modest or limited footprint in the state Medicaid population. In short, the provider does not appear to be a meaningful Medicaid provider in California based on the reported volumes and ranks.
Tenure and operational maturity: The provider’s NPI was enumerated on 2006-01-12 (~20 years ago), indicating an established practice history. Coupled with sustained high Medicare revenue ($6.1M) and repeated extreme-percentile procedure volumes across multiple interventional and diagnostic codes, the data support a long-running, high-volume vascular/cardiac interventional practice rather than a recently launched operation.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
85 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 37229 | N/A | 150 | $7,620 | $1.2M |
| 36482 | In this procedure, the provider inserts a chemical adhesive through a catheter into an incompetent vein in an extremity to ablate the vein. The provider reports this code for treatment of the first… | 340 | $1,600 | $542.1K |
| 37225 | N/A | 100 | $4,400 | $448.9K |
| 36247 | Angiography is an X–ray study of the blood vessels that helps physicians diagnose and treat medical conditions. Angiography uses a radiopaque substance (dye) to make the blood vessels visible under… | 550 | $690 | $373.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 3,150 | $110 | $330.6K |
| 78431 | The provider performs a PET myocardial imaging scan, a type of nuclear imaging test, with CT transmission scan that reveals blood flow to and from the heart (perfusion). Ejection fraction and… | 170 | $1,740 | $298.1K |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 580 | $420 | $241.9K |
| 37252 | In this add–on procedure, the provider inserts a specially designed catheter with an ultrasound transducer, a device that sends high–frequency sound waves through the tissues and detects their… | 260 | $850 | $225.2K |
| 36465 | In this procedure, the provider injects a noncompounded foam sclerosing solution into a single incompetent truncal vein of the extremity under ultrasound guidance to guide the dispersion of foam,… | 180 | $1,250 | $219.3K |
| 37238 | The physician inserts a stent in a vein using a catheter. Access may be either open or percutaneous. Radiological supervision and interpretation are included. | 60 | $3,270 | $199.3K |
Showing 1–10 of 85
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 85 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
85 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 37229 | 10 | 100 | 40 | $6,850 | $493.4K |
| 93229 | 34 | 350 | 40 | $890 | $468.8K |
| 37225 | 12 | 100 | 30 | $4,500 | $261K |
| 37227 | 36 | 50 | 20 | $8,650 | $259.5K |
| 78431 | 17 | 100 | 60 | $1,450 | $223.3K |
| 78492 | 57 | 140 | 90 | $1,180 | $220.2K |
| A9555 | 30 | 180 | 180 | $410 | $164.1K |
| 36482 | 4 | 100 | 40 | $1,520 | $135.2K |
| 36465 | 15 | 100 | 40 | $1,160 | $107.7K |
| 37239 | 3 | 10 | 100 | $1,100 | $97.5K |
Showing 1–10 of 85
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 60 | $20 | $1K |
| 93000 | The provider records the electrical conduction of the heart to examine any abnormality in its functioning, based on signals from at least 12 leads, wires that connect the recording device to… | 50 | $10 | $380 |
How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. California median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 10,875 | 13,300 | 640 | $40 | $169.6K |
| 93000 | The provider records the electrical conduction of the heart to examine any abnormality in its functioning, based on signals from at least 12 leads, wires that connect the recording device to… | 1,380 | 1,920 | 190 | $20 | $21.5K |
Other providers in the same ZIP code as Mehran Khorsandi, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Cedars-sinai Medical Center | CA | General Acute Care Hospital | $0 | $70M |
| The Los Angeles Free Clinic | CA | Federally Qualified Health Center (FQHC) | $0 | $31.8M |
| Arash Horizon | CA | Rheumatology Physician | $4.8M | $0 |
| Ernst Schwarz | CA | Cardiovascular Disease Physician | $1.1M | $1.7M |
| Robert Vescio | CA | Hematology & Oncology Physician | $2.1M | $0 |
| Kiarash Michel | CA | Urology Physician | $2.1M | $0 |
| Stephen Corday | CA | Internal Medicine Physician | $1.9M | $0 |
| Jay Schapira | CA | Interventional Cardiology Physician | $1.9M | $0 |
| Payam Yashar | CA | Cardiovascular Disease Physician | $1.9M | $0 |
| Rameen Moridzadeh | CA | Vascular Surgery Physician | $1.8M | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.